Cargando…

Understanding injecting drug use in Afghanistan: A scoping review

BACKGROUND: Several reports have described a growing prevalence of illicit drug use in Afghanistan, with recognition of a recent shift from traditional modes of consumption involving inhalation and oral ingestion to injecting drug use. OBJECTIVE: Conduct a comprehensive review of existing literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Nafeh, Frishta, Fusigboye, Sufiat, Sornpaisarn, Bundit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484158/
https://www.ncbi.nlm.nih.gov/pubmed/36123586
http://dx.doi.org/10.1186/s13011-022-00491-1
_version_ 1784791825418027008
author Nafeh, Frishta
Fusigboye, Sufiat
Sornpaisarn, Bundit
author_facet Nafeh, Frishta
Fusigboye, Sufiat
Sornpaisarn, Bundit
author_sort Nafeh, Frishta
collection PubMed
description BACKGROUND: Several reports have described a growing prevalence of illicit drug use in Afghanistan, with recognition of a recent shift from traditional modes of consumption involving inhalation and oral ingestion to injecting drug use. OBJECTIVE: Conduct a comprehensive review of existing literature to map the injecting drug use situation in Afghanistan. The review intends to describe risk factors and impacts of injecting drug use, drug use characteristics and risk behaviours among people who inject drugs (PWID), and access to harm reduction and treatment. METHODS: We searched Embase, Global Health, Medline, PsycINFO, Web of Science, and grey literature to identify English language publications up to March 26(th), 2022. Studies were eligible for inclusion if they explicitly targeted PWID or injecting drug use in Afghanistan and provided information relevant to the review questions. Two reviewers independently screened titles and abstracts for inclusion and extracted information based on the review objectives. RESULTS: A total of 25 articles were identified representing 15 studies (11 quantitative, 2 qualitative, 2 mixed methods). All but one studies were cross-sectional. In majority of the studies, over 95% of the participants were male and most were conducted over a decade ago, in urban settings, mainly Kabul. Only one study examined risk factors of injecting drug use. Eleven studies described drug use characteristics and 9 reported risk behaviours among PWID. Health and social burden of injecting drug use were reported by 8 and 5 studies, respectively. Nine studies described access to harm reduction and treatment. Afghan PWID had high levels of injecting and sexual risk behaviours compared to global estimates. They reported high prevalence of incarceration and displacement. Access to harm reduction and treatment was very limited. This scoping review revealed important knowledge gaps including a gender gap in research with serious implications for drug policy and substance use care. CONCLUSIONS: Development of a national public health-oriented drug policy and substance use care programme is warranted along with efforts to develop health research capacity to address the need for epidemiological data. The current humanitarian crisis necessitates continued access to evidence-based harm reduction and treatment in Afghanistan. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13011-022-00491-1.
format Online
Article
Text
id pubmed-9484158
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94841582022-09-20 Understanding injecting drug use in Afghanistan: A scoping review Nafeh, Frishta Fusigboye, Sufiat Sornpaisarn, Bundit Subst Abuse Treat Prev Policy Review BACKGROUND: Several reports have described a growing prevalence of illicit drug use in Afghanistan, with recognition of a recent shift from traditional modes of consumption involving inhalation and oral ingestion to injecting drug use. OBJECTIVE: Conduct a comprehensive review of existing literature to map the injecting drug use situation in Afghanistan. The review intends to describe risk factors and impacts of injecting drug use, drug use characteristics and risk behaviours among people who inject drugs (PWID), and access to harm reduction and treatment. METHODS: We searched Embase, Global Health, Medline, PsycINFO, Web of Science, and grey literature to identify English language publications up to March 26(th), 2022. Studies were eligible for inclusion if they explicitly targeted PWID or injecting drug use in Afghanistan and provided information relevant to the review questions. Two reviewers independently screened titles and abstracts for inclusion and extracted information based on the review objectives. RESULTS: A total of 25 articles were identified representing 15 studies (11 quantitative, 2 qualitative, 2 mixed methods). All but one studies were cross-sectional. In majority of the studies, over 95% of the participants were male and most were conducted over a decade ago, in urban settings, mainly Kabul. Only one study examined risk factors of injecting drug use. Eleven studies described drug use characteristics and 9 reported risk behaviours among PWID. Health and social burden of injecting drug use were reported by 8 and 5 studies, respectively. Nine studies described access to harm reduction and treatment. Afghan PWID had high levels of injecting and sexual risk behaviours compared to global estimates. They reported high prevalence of incarceration and displacement. Access to harm reduction and treatment was very limited. This scoping review revealed important knowledge gaps including a gender gap in research with serious implications for drug policy and substance use care. CONCLUSIONS: Development of a national public health-oriented drug policy and substance use care programme is warranted along with efforts to develop health research capacity to address the need for epidemiological data. The current humanitarian crisis necessitates continued access to evidence-based harm reduction and treatment in Afghanistan. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13011-022-00491-1. BioMed Central 2022-09-19 /pmc/articles/PMC9484158/ /pubmed/36123586 http://dx.doi.org/10.1186/s13011-022-00491-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Nafeh, Frishta
Fusigboye, Sufiat
Sornpaisarn, Bundit
Understanding injecting drug use in Afghanistan: A scoping review
title Understanding injecting drug use in Afghanistan: A scoping review
title_full Understanding injecting drug use in Afghanistan: A scoping review
title_fullStr Understanding injecting drug use in Afghanistan: A scoping review
title_full_unstemmed Understanding injecting drug use in Afghanistan: A scoping review
title_short Understanding injecting drug use in Afghanistan: A scoping review
title_sort understanding injecting drug use in afghanistan: a scoping review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484158/
https://www.ncbi.nlm.nih.gov/pubmed/36123586
http://dx.doi.org/10.1186/s13011-022-00491-1
work_keys_str_mv AT nafehfrishta understandinginjectingdruguseinafghanistanascopingreview
AT fusigboyesufiat understandinginjectingdruguseinafghanistanascopingreview
AT sornpaisarnbundit understandinginjectingdruguseinafghanistanascopingreview